Urologix, Inc. (ULGX) Reports Q2 Loss of $0.09

August 23, 2011 4:04 PM EDT
Urologix, Inc. (NASDAQ: ULGX) reported Q2 EPS of ($0.09), versus ($0.04) reported last year. Revenue for the quarter came in at $2.92 million, versus $3.26 million reported last year.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings